Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02296632 · ClinicalTrials.gov registry record
Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 7
- Enrollment target
NCT02296632: Completed study, sponsored by Cedars-Sinai Medical Center.
NCT02296632 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02296632 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This study aims to provide preliminary evidence of the validity of a sensor-based assessment of rheumatoid arthritis (RA) symptoms, and to collect structured qualitative feedback from RA Enbrel patients regarding the potential of a future biosensor/PRO mHealth application. The investigators' overarching hypothesis is that if patients have better and more timely information about whether Enbrel is working, then they will become more empowered and engaged in their treatment, more curious about how it may - or may not - be working, and potentially more compliant with therapy. However, this hypothesis remains largely untested.
Primary Outcome
We will conduct in-person interviews with participants to learn about their experiences wearing motion sensors and completing daily online assessments.
Interventions
- BEHAVIORAL Motion sensors and daily online assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-08 |
What the finished NCT02296632 record still lists
NCT02296632 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Motion sensors and daily online assessments is the first listed.
NCT02296632 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02296632 about?
NCT02296632 is a clinical study titled "Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study". This study aims to provide preliminary evidence of the validity of a sensor-based assessment of rheumatoid arthritis (RA) symptoms, and to collect structured qualitative feedback from RA Enbrel patients regarding the potential of a future biosensor/PRO mHealth application. The investigators' overarc...
What is the current status of trial NCT02296632?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2014-11. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02296632?
The interventions under investigation include: Motion sensors and daily online assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT02296632?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia